Iannone Robert

Reported to SECin USFilings at 3 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 18. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 18
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOOption exercisenothing paid27,584 sharesAug 31, 2026Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOnothing paidExercise · Aug 31Option exercise27,584Aug 31, 2026
Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOOption exercisenothing paid26,116 sharesAug 31, 2026Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOnothing paidExercise · Aug 31Option exercise26,116Aug 31, 2026
Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOOption exercisenothing paid2,916 sharesAug 31, 2026Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOnothing paidExercise · Aug 31Option exercise2,916Aug 31, 2026
Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOOption exercisenothing paid884 sharesAug 31, 2026Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOnothing paidExercise · Aug 31Option exercise884Aug 31, 2026
Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOOpen-market sell$75,828300 sharesAug 31, 2026Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMO$75,828Sell · Aug 31Open-market sell300Aug 31, 2026